{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:38:50Z","timestamp":1766407130232},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.06.015","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:27:15Z","timestamp":1289622435000},"page":"G30-G38","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S6","title":["Modelling the effect of conjugate vaccines in pneumococcal disease: Cohort or population models?"],"prefix":"10.1016","volume":"28","author":[{"given":"Baudouin","family":"Standaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Demarteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Talbird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Mauskopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2010.06.015_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.015_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices\u2014modeling studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.015_bib0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00019053-200624110-00002","article-title":"Recent developments in decision-analytic modelling for economic evaluation","volume":"24","author":"Weinstein","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2010.06.015_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10198-007-0078-x","article-title":"Decision-analytical modelling in health-care economic evaluations","volume":"9","author":"Sun","year":"2008","journal-title":"Eur J Health Econ"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.015_bib0025","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.clinthera.2009.10.014","article-title":"Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model","volume":"31","author":"De Wals","year":"2009","journal-title":"Clin Ther"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.06.015_bib0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0272989X04268953","article-title":"The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer","volume":"24","author":"Dewilde","year":"2004","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2010.06.015_bib0035","series-title":"Modeling biological populations in space and time","author":"Renshaw","year":"1991"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2010.06.015_bib0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.46579-0","article-title":"Control of pneumococcal disease in the United Kingdom--the start of a new era","volume":"55","author":"Clarke","year":"2006","journal-title":"J Med Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.015_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2005.02.008","article-title":"The current burden of pneumococcal disease in England and Wales","volume":"52","author":"Melegaro","year":"2006","journal-title":"J Infect"},{"issue":"May (4)","key":"10.1016\/j.vaccine.2010.06.015_bib0050","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","article-title":"Burden of paediatric invasive pneumococcal disease in Europe, 2005","volume":"135","author":"McIntosh","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"Apr (4 Suppl.)","key":"10.1016\/j.vaccine.2010.06.015_bib0055","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2010.06.015_bib0060","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.vaccine.2006.10.034","article-title":"Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination\u2014a review (2002\u20132006)","volume":"25","author":"Beutels","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl. 6","key":"10.1016\/j.vaccine.2010.06.015_bib0105","doi-asserted-by":"crossref","first-page":"G3","DOI":"10.1016\/j.vaccine.2010.06.013","article-title":"A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines","volume":"28","author":"Talbird","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.015_bib0070","series-title":"Poster presented at the 2nd Vaccine Global Congress","article-title":"Simulation model for comparing the costs and effectiveness of different pneumococcal conjugate vaccines","author":"De Wals","year":"2008"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2010.06.015_bib0075","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998-2003","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2010.06.015_bib0080","first-page":"144","article-title":"Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction\u2014eight states, 1998-2005","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.06.015_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0272989X09334419","article-title":"Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness","volume":"29","author":"Bauch","year":"2009","journal-title":"Med Decis Making"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2010.06.015_bib0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1524-4733.1998.140251.x","article-title":"Prevalence-based economic evaluation","volume":"1","author":"Mauskopf","year":"1998","journal-title":"Value Health"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2010.06.015_bib0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1524-4733.2000.34006.x","article-title":"Meeting the NICE requirements: a Markov model approach","volume":"3","author":"Mauskopf","year":"2000","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2010.06.015_bib0100","unstructured":"Mexican Institute of Social Security (IMSS). Directorate of Health Information. Database on dynamic cube format [updated 2008] Available from: http:\/\/sinais.salud.gob.mx\/basesdedatos\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T16:55:56Z","timestamp":1544115356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"alternative-id":["S0264410X10008133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}